维普中文期刊产品整合服务
42篇 您的检索式:作者名="Fuleihan"
    题名 作者 年代 出处 被引量
1Dual-energy X-ray absorptiometry of the forearm:reproducibility and correlation with single-photon absorptiometry显示文摘Leboff MS Fuleihan GE Angell JE 1992Journal of Bone & Mineral Research1992,7,7:1
2Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM显示文摘Fuleihan R Ramesh N Loh R 1993Proc Natl Acad Sci USA1993,90,6:1
3原发性免疫缺陷病患者肿瘤发生情况:美国免疫缺陷网络注册患者肿瘤发病率分析显示文摘研究背景评估了在美国免疫缺陷网络(USIDNET)注册的原发性免疫缺陷病(PIDDs)患者的总体和器官特异性肿瘤发病率,并与监测、流行病学和最终结果项目(SEER)数据库中经年龄校正的人群的肿瘤发病率进行比较。目的假设PIDD患者由于免疫功能受损,肿瘤发病率会增加。方法将2003年至2015年在USIDNET注册中心注册的PIDD (n=3658)患者的总体和器官特异性肿瘤发病率进行评估,并与SEER数据库中经年龄校正的人群发病率进行比较。结果与年龄相匹配的SEER人群相比,观察到PIDD患者罹患肿瘤的相对危险率为1. 42倍(P<0. 001)。PIDD的男性患癌症的风险是年龄校正的男性人群的1. 91倍(P<0. 001),而PIDD女性患者的总体肿瘤发病率与经年龄校正的女性人群相比并无差异。对SEER数据库中最常见的4个恶性肿瘤——肺癌、结肠癌、乳腺癌和前列腺癌的发病率进行分析,PIDD患者中这些肿瘤的发病没有显著增加。男性和女性PIDD患者的淋巴瘤发病率均显著增加(男性10倍,P<0. 001;女性8. 34倍,P<0. 001)。结论 PIDD患者的肿瘤发病率较高。在特定的PIDD人群中淋巴瘤发病率的增高是导致总体肿瘤发病率提高的主要原因,而常见的实体肿瘤的风险没有增加。这些数据表明免疫系统在预防特定肿瘤方面有一定的作用。Paul C.Mayor Kevin H.Eng Kelly L.Singel Scott I.Abrams Kunle Odunsi Kirsten B.Moysich Ramsay Fuleihan Elizabeth Garabedian Patricia Lugar Hans D.Ochs Francisco A.Bonilla Rebecca H.Buckley Kathleen E.Sullivan Zuhair K.Ballas Charlotte Cunningham-Rundles Brahm H.Segal 白炜 曾小峰 2018中华临床免疫和变态反应杂志2018,12,2:1
4Summary statement from a workshop on asympto matic primary hyperparathyroidism:a perspective for the 21st century显示文摘 Potts JT Jr Fuleihan Gel-H 2002J Bone Miner Res2002,172,:1
5The hygiene hypothesis revisited: dose exposure to infectious agents protect us from allergy? 显示文摘Fishbein AB Fuleihan RL 2012Curt Opin Pediatr2012,24,1:1
6Effect of vitamin D replacement on musculoskelctal parameters in school children:A randomized controlled trial 显示文摘Fuleihan G Nabulsi M Tamin H 2006J Clin Endocrinol Metab2006,91,2:1
7Endocrine and musculo- skeletal abnormalities in patients with Down syndrome显示文摘Hawli Y Nasrallah M E1 - Hajj Fuleihan G 2009Nat Rev En- docrinol2009,5,6:1
8Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiencywith normal or elevated IgM显示文摘Fuleihan R Ramesh N Loh R 1993Proc Natl Acad Sci USA1993,90,6:1
9Global vitamin D status and determinants of hypovitaminosis D显示文摘A. Mithal D. A. Wahl J.-P. Bonjour P. Burckhardt B. Dawson-Hughes J. A. Eisman G. El-Hajj Fuleihan R. G. Josse P. Lips J. Morales-Torres 2009Osteoporosis International2009,,:1
10Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century 显示文摘Bilezikian JP Potts JT Jr Fuleihan Gel-H 2002J Clin Endocrinol Metab2002,87,12:1
11Dermatologic manifestations of para- thyroid- related disorders显示文摘Fuleihan GE Rubeiz N 2006Clinics in Dermatology2006,24,4:1
12A dyslexia-associated variant in DCDC2 changes gene expression显示文摘Meng H Powers NR Tang L Cope NA Zhang PX Fuleihan R 0,,01:1
13Hypovitaminosis D in healthy school children显示文摘El Hajj Fuleihan G Nabulsi M Choucair M 2001Pediatrics2001,107,4:1
14DOCK8 deficiency, T cell receptor excision circles and newborn screening 显示文摘Fuleihan RL 2011Clin Immunol2011,141,2:1
15Strontium ranelate:a novel therapy for osteoporosis or a permutation of the same? 显示文摘El-Hajj Fuleihan G 2004N Engl J Med2004,350,5:1
16Effects of sublingual nitroglycerin on resting pulmonary gas exchange and haemodynamics in man 显示文摘Mookherjee S Fuleihan D Wamer RA 1978Circulation1978,57,1:1
17The hyper IgM syndrome 显示文摘FULEIHAN R L 2001Curr Allergy Asthma Rep2001,1,5:1
18Predictors of bone density in ambulatory patients on antiepileptic drugs 显示文摘El-Hajj Fuleihan G Dib L Yamout B 2008Bone2008,43,1:1
19Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism:A Perspective for the 21st Century显示文摘Bilezikian JP Potts JT Fuleihan Gel-H 2002The Journal of Clinical Endocrinology & Metabolism2002,87,12:1
20CD40 ligand - deficient T cells from X - linked hyper - IgM syndrome carriers have intrinsic priming capability 显示文摘LOBO F M SCHOLL P R FULEIHAN R L 2002J Immunolo2002,168,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费